Health Trials

Implications of Biological and Procedural Factors of 18-f FDG Uptake by Normal Organs and Neoplastic Lesions

ConditionOncologic Diseases
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-90
Sponsormahenoor alaa eldeen naem

About this trial

To evaluate implications of biological and procedural factors of 18-f FDG PET/CT uptake on normal organs and neoplastic lesions.

Eligibility criteria

Qualifiers

cancer patients referred to nuclear medicine unit

Disqualifiers

patients with increased FDG uptake associated with non malignant causes such as diffuse bone marrow FDG uptake or lung infection or patients with extensive metastasis in target organs

Trial design

Treatments tested in this trial

  • 18 FDG (Fludeoxyglucose 18F)

Treatment groups

No treatment groups listed

Sponsors and collaborators

mahenoor alaa eldeen naem

Lead sponsor

Assiut University

Sponsor institution

Source ClinicalTrials.gov